Key Record Dates
| ClinicalTrials.gov Identifier: | NCT02985957 |
|---|---|
| Brief Title: | Study of Nivolumab Plus Ipilimumab, Ipilimumab or Cabazitaxel in Men With Metastatic Castration-Resistant Prostate Cancer (CheckMate 650) |
| First Submitted : | November 22, 2016 |
| First Submitted that Met QC Criteria : | December 5, 2016 |
| First Posted : | December 7, 2016 (Estimate) |
| Last Update Submitted that Met QC Criteria : | October 15, 2020 |
| Last Update Posted : | October 19, 2020 |